Np Life Sciences Health Industry Group Inc (NPLS) Growth Rates Comparisons to Educational Services Industry, Sector, Market. Sales, Income, EPS
CSIMarket
 
Np Life Sciences Health Industry Group Inc   (NPLS)
    Sector  Services    Industry Educational Services
   Industry Educational Services
   Sector  Services
 

Np Life Sciences Health Industry Group Inc Growth Comparisons

Select each growth Category to receive further Information





NPLS Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q4 MRQ) -78.26 % 9.2 % 2.34 % 1.01 %
Q / Q Revenue Growth (Q4 MRQ) -42.87 % 6.16 % 1.3 % 1.24 %
Y / Y Revenue Growth (for 12 months ending Q4 TTM) -52.65 % 12.93 % 10.96 % %
Sequential Revenue Growth (for 12 months ending Q4 TTM) -17.95 % 3.21 % 7.31 % 0.33 %
Revenue 5 Year Average Growth - 12.51 % 6.58 % 7.24 %


NPLS's Growth Comparisons in IV. Quarter 2023




Np Life Sciences Health Industry Group Inc reported top-line of $ 0 millions in the fourth quarter 2023, compare to $ 0 millions in the same quarter a year ago. Revenues in the Educational Services industry grew by 9.2%, while the top-line in the Services sector increased by 2.34%, and overall market improved by 1.01% from the fourth quarter 2022.

Top-line fell by -42.87% from the third quarter results. Comparing the annual growth, sales of % on average in last five years, to the S & P 500's, including only Businesses with the fourth quarter 2023 financial results, average yearly sales growth is 7.24%. Np Life Sciences Health Industry Group Inc grew less than the market.


Growth Rates of NPLS's Income in the fourth quarter 2023


NPLS Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q4 MRQ) - 96.93 % 91.62 % 2.01 %
Sequential Operating Income Change (Q4 MRQ) - 853.07 % -27.04 % -4.59 %
Y / Y Operating Income Growth (Q4 TTM) - 30.2 % 44.41 % -4.4 %
Sequential Operating Income Growth (Q4 TTM) - 34.03 % 30.66 % -0.46 %
Operating Income 5 Year Avg. Change - 3.89 % 9.27 % 8.94 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q4 MRQ) - - 115.7 % 6.55 %
Sequential Income from Cont. Ops. Change (Q4 MRQ) - 232.33 % -75.13 % -13.27 %
Y / Y Income from Cont. Ops. Change (Q4 TTM) 28.89 % 35.57 % 83.39 % -1.21 %
Sequential Income from Cont. Ops. Change (Q4 TTM) -60.98 % 20.58 % 42.87 % 1.89 %
Income from Cont. Ops. 5 Year Avg. Change - 11.47 % 1.44 % 6.24 %

NPLS Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q4 MRQ) - 94.39 % - 2.53 %
Q / Q Net Income Growth (Q4 MRQ) - 448.38 % -75.68 % -19.48 %
Y / Y Net Income Change (Q4 TTM) - -16.86 % 68.04 % -0.13 %
Sequential Net Income Change (Q4 TTM) - 24.83 % 39.46 % 0.95 %
Net Income 5 Year Avg. Growth - -8.28 % -0.59 % 5.47 %

NPLS's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q4 MRQ) - - 115.7 % 6.55 %
Sequential EPS from Cont. Ops. Change (Q4 MRQ) - 227.5 % -75.13 % -13.27 %
Y / Y EPS from Cont. Ops. Change (Q4 TTM) - - - -
Sequential EPS from Cont. Ops. Change (Q4 TTM) - - - 0 %
EPS from Cont. Ops. 5 Year Avg. Growth - -9.53 % 1.44 % 6.24 %



NPLS EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q4 MRQ) - 96.4 % - 6.24 %
Q / Q EPS Net Growth (Q4 MRQ) - 440.41 % -75.68 % -19.48 %
Y / Y EPS Net Change (for 12 months ending Q4 TTM) - - - 38439.69 %
Sequential EPS Net Change (for 12 months ending Q4 TTM) - - - 0.03 %
EPS Net 5 Year Avg. Change - -8.28 % -0.59 % 5.47 %



Np Life Sciences Health Industry Group Inc reported bottom-line of $ 0.00 in the fourth quarter, compare to $ 0.00 in the same quarter a year ago. Educational Services industry grew by 96.4%, while Services sector increased by 2.34%, and overall market improved by 2.53%.

Bottom-line fell by -42.87% from the third quarter results. Comparing the annual growth, income per share of % on average in last five years, to the S & P 500's, including only Businesses with the fourth quarter 2023 earnings, average yearly income per share growth is 5.47%. Np Life Sciences Health Industry Group Inc grew less than the market.

NPLS Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q4 MRQ) - 137.19 % -6.89 % -5.16 %
Sequential Free Cash Flow Change (Q4 MRQ) - 76.22 % -29.66 % -4.82 %
Y / Y Free Cash Flow Change (Q4 TTM) - 85.46 % 94 % 4.99 %
Sequential Free Cash Flow Change (Q4 TTM) - 46.97 % 54.74 % 5.63 %
Free Cash Flow 5 Year Avg. Change - 7.99 % 11.73 % 8.95 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q4 MRQ) - -41.8 % - -
Sequential Net Cash Flow Change (Q4 MRQ) - - - -
Y / Y Net Cash Flow Change (Q4 TTM) - - - -
Sequential Net Cash Flow Change (Q4 TTM) - - 10093.65 % 524.43 %
Net Cash Flow 5 Year Avg. Change - - 8.31 % -33.51 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q4 MRQ) - -10.69 % -9.15 % -10.32 %
Sequential Capital Expenditures Change (Q4 MRQ) - -6.77 % 8.55 % -0.97 %
Y / Y Capital Expenditures Change (Q4 TTM) - 12.11 % 49.24 % 30.83 %
Sequential Capital Expenditures Change (Q4 TTM) - 11.97 % 40.84 % 35.84 %
Capital Expenditures 5 Year Avg. Change - -6.21 % 11.12 % 8.85 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.